Olanzapine as Citrate

AIT Pharmaceuticals Division: Your Partner in Mental Health

 

Introduction:

Welcome to AIT Pharmaceuticals Division, where we prioritize mental well-being through innovative pharmaceutical solutions. Our commitment to excellence and patient care is exemplified in our Olanzapine as Citrate Range, a cutting-edge medication designed to address a range of psychiatric conditions.

 

Pharmacokinetics and Pharmacodynamics:

Olanzapine, as citrate, is classified as an atypical antipsychotic medication. It exerts its therapeutic effects by antagonizing dopamine and serotonin receptors in the brain, effectively managing symptoms of psychosis, including hallucinations, delusions, and disorganized thinking. By modulating neurotransmitter activity, olanzapine helps restore balance and alleviate psychiatric symptoms.

Share

Description

Drug Classification:

Olanzapine belongs to the class of atypical antipsychotics, renowned for their efficacy and improved side effect profile compared to traditional antipsychotic agents. Its unique mechanism of action makes it a versatile option for the treatment of schizophrenia, bipolar disorder, and other psychiatric disorders.

Formulations:

Our Olanzapine as Citrate Range is available in tablet form, with strengths of 5 mg and 10 mg. Each pack contains 10 tablets, providing a convenient and standardized dosage regimen for patients requiring psychiatric treatment.

Indications:

Olanzapine is indicated for the management of schizophrenia, a chronic and debilitating mental illness characterized by disturbances in thought, perception, and behavior. Additionally, it is approved for the treatment of bipolar disorder, including acute manic or mixed episodes and long-term maintenance therapy to prevent recurrence of mood episodes.

Usage:

Olanzapine tablets should be taken orally, with or without food, as directed by a healthcare professional. The dosage regimen may vary depending on the specific condition being treated, the severity of symptoms, and individual patient factors. It is essential to follow the prescribed dosage instructions and adhere to the treatment plan for optimal therapeutic outcomes.

Dosage:

The recommended starting dose of Olanzapine for schizophrenia is typically 10 mg once daily, with adjustments made based on response and tolerability. For bipolar disorder, the initial dose may be lower, ranging from 5 mg to 10 mg daily. Dosage adjustments should be made cautiously and under medical supervision to minimize the risk of adverse effects.

Side Effects:

Common side effects of Olanzapine may include drowsiness, weight gain, increased appetite, dry mouth, and constipation. Less frequent but potentially serious side effects may include extrapyramidal symptoms, metabolic changes, orthostatic hypotension, and hyperprolactinemia. Patients should be monitored regularly for adverse reactions, and healthcare providers should be informed of any concerning symptoms.

Conclusion:

Trust AIT Pharmaceuticals Division for compassionate and comprehensive mental health care with our Olanzapine as Citrate Range. Empower yourself or your loved ones to overcome psychiatric challenges and embrace a brighter future with our advanced medication. Choose AIT Pharmaceuticals Division for personalized support and effective treatment options tailored to your needs.

Reviews

There are no reviews yet.

Be the first to review “Olanzapine as Citrate”

Your email address will not be published. Required fields are marked *

Shopping Basket